Pacira BioSciences : Reports Preliminary Net Product Sales for EXPAREL and iovera° of $46.0 Million for May 2022 - Form 8-K

Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $46.0 Million for May 2022





- EXPAREL average daily sales for May 2022... | June 14, 2022

Related Keywords

California ,United States ,San Diego ,Pacira Biosciences ,Susan Mesco ,Kristin Capone ,Pacira Biosciences Inc ,Drug Administration ,Nasdaq ,Exchange Commission ,Intrathecal Administration ,European Medicines Agency Marketing Authorization Applications ,Flexion Therapeutics Inc ,Dave Stack ,Flexion Therapeutics ,Safety Information ,Select Important Safety Information ,Intra Articular Use Only ,Serious Neurologic Adverse Reactions ,Private Securities Litigation Reform Act ,United States Food ,New Drug Applications ,Annual Report ,Nc Stock Exchange ,News ,Information ,Press Release ,Pacira ,Iosciences ,Reports ,Reliminary ,Pet ,Product ,Sales ,Or ,Exparel ,End ,F ,Billion ,Bay ,Average ,Daily ,Ay Pcrx Us6951271005 ,